Ardavan Akhavan1, Daniel Avery1, Thomas S Lendvay2. 1. Division of Pediatric Urology, Seattle Children's Hospital, 4800 Sand Point Way, NE, Seattle, WA 98105, USA. 2. Division of Pediatric Urology, Seattle Children's Hospital, 4800 Sand Point Way, NE, Seattle, WA 98105, USA. Electronic address: Thomas.lendvay@seattlechildrens.org.
Abstract
OBJECTIVE: Extravesical robot-assisted laparoscopic ureteral reimplantation (RALUR) is a popular alternative to open surgery. We report our experience with RALUR and evaluate clinical variables as predictors for failure. METHODS: We retrospectively evaluated the records of patients who underwent RALUR by a single surgeon for treatment of primary vesicoureteral reflux. Clinical and demographic variables were determined. Clinical variables were compared with surgical outcomes using the Student two-tailed type 2 t test. RESULTS: Fifty patients underwent a combined 78 extravesical RALURs. Median (range) age was 6.2 (1.9-18.0) years; median (range) preoperative reflux grade was 3 (0-5). Dysfunctional elimination syndrome (DES) was present in 32 (64%). Ten (20%) patients had prior deflux, and two (4%) had prior ureteroneocystostomy on the ipsilateral side. Postoperative cystogram was performed in 100% at a median (range) of 55 (27-133) days. Median (range) follow-up was 286 (27-2238) days. Febrile urinary tract infection occurred in five (10%), none of whom had reflux on initial follow-up postoperative cystogram. All five had a history of DES and were female. Six complications occurred in five (10%) patients, including ileus (2), ureteral obstruction (2), ureteral injury (1), and perinephric fluid collection (1). Transient urinary retention occurred in one. Five of 22 (22.7%) patients undergoing unilateral surgery had contralateral de novo reflux. Six of 78 ureters (7.7%) had persistent reflux postoperatively. Neither persistent nor de novo reflux was associated with any of the clinical variables assessed. CONCLUSIONS: RALUR is an effective and safe option for patients with primary vesicoureteral reflux requiring surgery.
OBJECTIVE: Extravesical robot-assisted laparoscopic ureteral reimplantation (RALUR) is a popular alternative to open surgery. We report our experience with RALUR and evaluate clinical variables as predictors for failure. METHODS: We retrospectively evaluated the records of patients who underwent RALUR by a single surgeon for treatment of primary vesicoureteral reflux. Clinical and demographic variables were determined. Clinical variables were compared with surgical outcomes using the Student two-tailed type 2 t test. RESULTS: Fifty patients underwent a combined 78 extravesical RALURs. Median (range) age was 6.2 (1.9-18.0) years; median (range) preoperative reflux grade was 3 (0-5). Dysfunctional elimination syndrome (DES) was present in 32 (64%). Ten (20%) patients had prior deflux, and two (4%) had prior ureteroneocystostomy on the ipsilateral side. Postoperative cystogram was performed in 100% at a median (range) of 55 (27-133) days. Median (range) follow-up was 286 (27-2238) days. Febrile urinary tract infection occurred in five (10%), none of whom had reflux on initial follow-up postoperative cystogram. All five had a history of DES and were female. Six complications occurred in five (10%) patients, including ileus (2), ureteral obstruction (2), ureteral injury (1), and perinephric fluid collection (1). Transient urinary retention occurred in one. Five of 22 (22.7%) patients undergoing unilateral surgery had contralateral de novo reflux. Six of 78 ureters (7.7%) had persistent reflux postoperatively. Neither persistent nor de novo reflux was associated with any of the clinical variables assessed. CONCLUSIONS: RALUR is an effective and safe option for patients with primary vesicoureteral reflux requiring surgery.
Authors: Briony K Varda; Ye Wang; Benjamin I Chung; Richard S Lee; Michael P Kurtz; Caleb P Nelson; Steven L Chang Journal: J Pediatr Urol Date: 2018-02-22 Impact factor: 1.830
Authors: Zachary R Dionise; Juan Marcos Gonzalez; Michael L Garcia-Roig; Andrew J Kirsch; Charles D Scales; John S Wiener; J Todd Purves; Jonathan C Routh Journal: Urology Date: 2019-03-14 Impact factor: 2.649
Authors: Hsin-Hsiao S Wang; Rohit Tejwani; Glenn M Cannon; Patricio C Gargollo; John S Wiener; Jonathan C Routh Journal: J Pediatr Urol Date: 2016-04-16 Impact factor: 1.830
Authors: Ciro Esposito; Lorenzo Masieri; Henri Steyaert; Maria Escolino; Raffaele Cerchione; Angela La Manna; Chiara Cini; Thomas S Lendvay Journal: World J Urol Date: 2017-12-16 Impact factor: 4.226